Early Stages of Diffuse Idiopathic Skeletal Hyperostosis (DISH) and Chronic Inflammation: the Camargo Cohort Study

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2023 Mar 18

PMID 36933072

Authors

Emilio Pariente

Stefanie F Pini

Jose M Olmos

Patricia Fierro

Rosa Landeras

Carmen Ramos

Victor M Martinez-Taboada

Jose L Hernandez

Affiliations

Soon will be listed here.

Abstract

Introduction/objectives: DISH has traditionally been considered a non-inflammatory rheumatic disorder. Currently, an inflammatory component has been theorized in the early phases of this condition (EDISH). The study is aimed at investigating a possible relationship between EDISH and chronic inflammation.

Method: Analytical-observational study: participants from the Camargo Cohort Study were enrolled. We collected clinical, radiological, and laboratory data. C-reactive protein (CRP), albumin-to-globulin ratio (AGR), and triglyceride-glucose (TyG) index were assessed. EDISH was defined by Schlapbach's scale grades I or II. A fuzzy matching with tolerance factor = 0.2 was performed. Subjects without ossification (NDISH), sex- and age-matched with cases (1:4), acted as controls. Definite DISH was an exclusion criterion. Multivariable analyses were performed.

Results: We evaluated 987 persons (mean age 64 ± 8 years; 191 cases with 63.9% women). EDISH subjects presented more frequently obesity, T2DM, MetS, and the lipid pattern [↑TG ↓TC]. TyG index and alkaline phosphatase (ALP) were higher. Trabecular bone score (TBS) was significantly lower (1.310 [0.2] vs. 1.342 [0.1]; p = 0.025). CRP and ALP showed the highest correlation (r = 0.510; p = 0.0001) at lowest TBS level. AGR was lower, and its correlations with ALP (r = - 0.219; p = 0.0001) and CTX (r = - 0.153; p = 0.022), were weaker or non-significant in NDISH. After adjustment for potential confounders, estimated CRP means for EDISH and NDISH were 0.52 (95% CI: 0.43-0.62) and 0.41 (95% CI: 0.36-0.46), respectively (p = 0.038).

Conclusions: EDISH was associated with chronic inflammation. Findings revealed an interplay between inflammation, trabecular impairment, and the onset of ossification. Lipid alterations were similar to those observed in chronic-inflammatory diseases. Key Points • An inflammatory component has been theorized in early stages of DISH (EDISH) • In EDISH group compared to non-DISH, we observed significantly higher correlations between biomarkers and some relevant variables. In particular, with alkaline phosphatase (ALP) and with trabecular bone score (TBS) • EDISH has shown to be associated with chronic inflammation • The lipid alterations observed in the EDISH group were similar to those observed in chronic-inflammatory diseases.

Citing Articles

Imaging of Sacroiliac Pain: The Current State-of-the-Art.

Carotti M, Ceccarelli L, Poliseno A, Ribichini F, Bandinelli F, Scarano E J Pers Med. 2024; 14(8).

PMID: 39202065 PMC: 11355172. DOI: 10.3390/jpm14080873.

Examining the Association Between the Extent of Anterior Longitudinal Ligament Ossification Progression and Comorbidities in Diffuse Idiopathic Skeletal Hyperostosis.

Ishimura D, Morino T, Murakami Y, Yamaoka S, Kinoshita T, Takao M Cureus. 2024; 15(12):e51357.

PMID: 38292970 PMC: 10824704. DOI: 10.7759/cureus.51357.

Diffuse Idiopathic Skeletal Hyperostosis (DISH): Role of Logopedic Rehabilitation in Dysphagia.

Mesolella M, Buono S, DAniello R, Ascione A, Motta G, Allosso S J Pers Med. 2023; 13(6).

PMID: 37373983 PMC: 10302711. DOI: 10.3390/jpm13060994.

References

Forestier J, ROTES-QUEROL J . Senile ankylosing hyperostosis of the spine. Ann Rheum Dis. 1950; 9(4):321-30. PMC: 1011670. DOI: 10.1136/ard.9.4.321. View

Resnick D, Shapiro R, Wiesner K, Niwayama G, Utsinger P, SHAUL S . Diffuse idiopathic skeletal hyperostosis (DISH) [ankylosing hyperostosis of Forestier and Rotes-Querol]. Semin Arthritis Rheum. 1978; 7(3):153-87. DOI: 10.1016/0049-0172(78)90036-7. View

Mader R, Verlaan J, Buskila D . Diffuse idiopathic skeletal hyperostosis: clinical features and pathogenic mechanisms. Nat Rev Rheumatol. 2013; 9(12):741-50. DOI: 10.1038/nrrheum.2013.165. View

Dabrowski M, Kubaszewski L . Diffuse Idiopathic Skeletal Hyperostosis of Cervical Spine with Dysphagia-Molecular and Clinical Aspects. Int J Mol Sci. 2021; 22(8). PMC: 8074005. DOI: 10.3390/ijms22084255. View

Li H, Jiang L, Dai L . Hormones and growth factors in the pathogenesis of spinal ligament ossification. Eur Spine J. 2007; 16(8):1075-84. PMC: 2200765. DOI: 10.1007/s00586-007-0356-4. View

Niu C, Lin S, Yuan L, Chen L, Yang C, Chung A . Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL. BMC Musculoskelet Disord. 2017; 18(1):61. PMC: 5290649. DOI: 10.1186/s12891-017-1425-4. View

Olivieri I, DAngelo S, Palazzi C, Padula A, Mader R, Khan M . Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis. Curr Rheumatol Rep. 2009; 11(5):321-8. DOI: 10.1007/s11926-009-0046-9. View

Mader R, Pappone N, Baraliakos X, Eshed I, Sarzi-Puttini P, Atzeni F . Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component. Curr Rheumatol Rep. 2021; 23(1):6. DOI: 10.1007/s11926-020-00972-x. View

Denko C, Boja B, Malemud C . Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Front Biosci. 2002; 7:a37-43. DOI: 10.2741/denko. View

10.

Mader R, Novofastovski I, Iervolino S, Pavlov A, Chervinsky L, Schwartz N . Ultrasonography of peripheral entheses in the diagnosis and understanding of diffuse idiopathic skeletal hyperostosis (DISH). Rheumatol Int. 2014; 35(3):493-7. DOI: 10.1007/s00296-014-3190-0. View

11.

Latourte A, Charlon S, Etcheto A, Feydy A, Allanore Y, Dougados M . Imaging Findings Suggestive of Axial Spondyloarthritis in Diffuse Idiopathic Skeletal Hyperostosis. Arthritis Care Res (Hoboken). 2017; 70(1):145-152. DOI: 10.1002/acr.23244. View

12.

Kuperus J, Waalwijk J, Regan E, van der Horst-Bruinsma I, Oner F, de Jong P . Simultaneous occurrence of ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: a systematic review. Rheumatology (Oxford). 2018; 57(12):2120-2128. DOI: 10.1093/rheumatology/key211. View

13.

Pillai S, Littlejohn G . Metabolic factors in diffuse idiopathic skeletal hyperostosis - a review of clinical data. Open Rheumatol J. 2015; 8:116-28. PMC: 4293739. DOI: 10.2174/1874312901408010116. View

14.

Glick K, Novofastovski I, Schwartz N, Mader R . Cardiovascular disease in diffuse idiopathic skeletal hyperostosis (DISH): from theory to reality-a 10-year follow-up study. Arthritis Res Ther. 2020; 22(1):190. PMC: 7430040. DOI: 10.1186/s13075-020-02278-w. View

15.

Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C . Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019; 25(12):1822-1832. PMC: 7147972. DOI: 10.1038/s41591-019-0675-0. View

16.

Kuperus J, de Gendt E, Oner F, de Jong P, Buckens S, van der Merwe A . Classification criteria for diffuse idiopathic skeletal hyperostosis: a lack of consensus. Rheumatology (Oxford). 2017; 56(7):1123-1134. DOI: 10.1093/rheumatology/kex056. View

17.

Bieber A, Masala I, Mader R, Atzeni F . Differences between diffuse idiopathic skeletal hyperostosis and spondyloarthritis. Immunotherapy. 2020; 12(10):749-756. DOI: 10.2217/imt-2020-0045. View

18.

Hernandez J, Olmos J, Pariente E, Martinez J, Valero C, Garcia-Velasco P . Metabolic syndrome and bone metabolism: the Camargo Cohort study. Menopause. 2010; 17(5):955-61. DOI: 10.1097/gme.0b013e3181e39a15. View

19.

Levey A, Stevens L, Schmid C, Zhang Y, Castro 3rd A, Feldman H . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. PMC: 2763564. DOI: 10.7326/0003-4819-150-9-200905050-00006. View

20.

Alberti K, Zimmet P, Shaw J . Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006; 23(5):469-80. DOI: 10.1111/j.1464-5491.2006.01858.x. View